// App-Quantinova.ai

Tu1641 : VAGAL AFFERENT DYSFUNCTION INVOLVES SUPPRESSOR OF CYTOKINE SIGNALING-3 (SOCS3) MEDIATED NITRIC OXIDE PRODUCTION IN DIET-INDUCED OBESITY AND ELEVATED LEPTIN CONDITIONS

Researchers

Presenter

  • Michael Beyak

Principal Investigators

  • N/A

Medical Centers

  • Gastroenterology / Medicine, Queen's University, Kingston, Ontario, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

Disease

  • N/A

Biomarkers

  • Leptin

  • Suppressor Of Cytokine Signaling 3

Drug/Treatment

  • Zoledronic acid

  • Nitric oxide

Outcome

  • Unknown

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved